Mittal Srabani, Mandal Ranajit, Banerjee Dipanwita, Das Pradip, Ghosh Ishita, Panda Chinmay, Biswas Jaydip, Basu Partha
Chittaranjan National Cancer Institute, 37, S. P. Mukherjee Road, Kolkata, 700026, India.
Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer (WHO), 150 Cours Albert Thomas, 69372, Lyon Cedex 08, France.
Cancer Causes Control. 2016 Mar;27(3):351-8. doi: 10.1007/s10552-015-0708-z. Epub 2015 Dec 28.
A demonstration project was conducted to assess feasibility of implementing HPV detection-based cervical cancer screening in primary care settings in India and to generate local evidence on feasibility and effectiveness of HPV detection in primary screening.
The project was implemented by setting up screening clinics at primary health centers. Eligible women were screened by HPV DNA test (Hybrid capture 2). All samples were processed and tested in a single laboratory. Colposcopy services were provided to screen-positive women at the same community clinics. Project utilized services of community health workers for community mobilization, recall of screen-positive and disease-positive women. Women with ≥CIN2 diagnosis were treated at tertiary hospital.
Totally, 44,110 women were screened and HPV positivity was 4.7 %. Compliance to recall of HC2-positive women for colposcopy was 78 %. Detection rate of CIN3+ by HPV test was 3.9/1,000 women. Compliance of women to treatment was 80.1 %. However, compliance of HPV-positive women for follow-up at 1 year was poor (23.2 %). Concurrent use of VIA to screen the women did not have any advantage but increased number of unnecessary colposcopies and biopsies.
Our project demonstrated that it was possible to implement HPV detection-based screening using existing primary healthcare infrastructure. Performing colposcopy at primary setting is feasible, improves compliance and reduces over-treatment. In settings with low to moderately high HPV prevalence, direct referral of HPV-positive women is advisable. Community health workers can be effectively used for recalling the positive women.
开展一项示范项目,以评估在印度初级保健机构实施基于人乳头瘤病毒(HPV)检测的宫颈癌筛查的可行性,并收集关于HPV检测在初级筛查中的可行性和有效性的本地证据。
通过在初级卫生中心设立筛查诊所来实施该项目。符合条件的女性接受HPV DNA检测(杂交捕获2法)。所有样本均在单一实验室进行处理和检测。在同一社区诊所为筛查呈阳性的女性提供阴道镜检查服务。该项目利用社区卫生工作者的服务进行社区动员,召回筛查呈阳性和疾病呈阳性的女性。诊断为≥CIN2的女性在三级医院接受治疗。
总共对44,110名女性进行了筛查,HPV阳性率为4.7%。HC2阳性女性接受阴道镜检查的召回依从率为78%。HPV检测对CIN3+的检出率为3.9/1000名女性。女性的治疗依从率为80.1%。然而,HPV阳性女性1年随访的依从性较差(23.2%)。同时使用醋酸肉眼观察法(VIA)对女性进行筛查没有任何优势,反而增加了不必要的阴道镜检查和活检的数量。
我们的项目表明,利用现有的初级医疗基础设施实施基于HPV检测的筛查是可行的。在初级医疗机构进行阴道镜检查是可行的,可提高依从性并减少过度治疗。在HPV患病率低至中高的地区,建议直接将HPV阳性女性转诊。社区卫生工作者可有效地用于召回阳性女性。